AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

NCT06951503 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Adenocarcinoma

Interventions

DRUG: AK112
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Leucovorin and 5-FU
DRUG: Bevacizumab

Sponsor

Akeso